TY - JOUR
T1 - FOXC2 mutations in familial and sporadic spinal extradural arachnoid cyst
AU - Ogura, Yoji
AU - Yabuki, Shoji
AU - Iida, Aritoshi
AU - Kou, Ikuyo
AU - Nakajima, Masahiro
AU - Kano, Hiroki
AU - Shiina, Masaaki
AU - Kikuchi, Shinichi
AU - Toyama, Yoshiaki
AU - Ogata, Kazuhiro
AU - Nakamura, Masaya
AU - Matsumoto, Morio
AU - Ikegawa, Shiro
PY - 2013/11/22
Y1 - 2013/11/22
N2 - Spinal extradural arachnoid cyst (SEDAC) is a cyst in the spinal canal that protrudes into the epidural space from a defect in the dura mater. Most cases are sporadic; however, three familial SEDAC cases have been reported, suggesting genetic etiological factors. All familial cases are associated with lymphedema-distichiasis syndrome (LDS), whose causal gene is FOXC2. However, FOXC2 mutation analysis has been performed in only 1 family, and no mutation analysis has been performed on sporadic (non-familial) SEDACs. We recruited 17 SEDAC subjects consisting of 2 familial and 7 sporadic cases and examined FOXC2 mutations by Sanger sequencing and structural abnormalities by TaqMan copy number assay. We identified 2 novel FOXC2 mutations in 2 familial cases. Incomplete LDS penetrance was noted in both families. Four subjects presented with SEDACs only. Thus, SEDAC caused by the heterozygous FOXC2 loss-of-function mutation should be considered a feature of LDS, although it often manifests as the sole symptom. Seven sporadic SEDAC subjects had no FOXC2 mutations, no symptoms of LDS, and showed differing clinical characteristics from those who had FOXC2 mutations, suggesting that other gene(s) besides FOXC2 are likely to be involved in SEDAC.
AB - Spinal extradural arachnoid cyst (SEDAC) is a cyst in the spinal canal that protrudes into the epidural space from a defect in the dura mater. Most cases are sporadic; however, three familial SEDAC cases have been reported, suggesting genetic etiological factors. All familial cases are associated with lymphedema-distichiasis syndrome (LDS), whose causal gene is FOXC2. However, FOXC2 mutation analysis has been performed in only 1 family, and no mutation analysis has been performed on sporadic (non-familial) SEDACs. We recruited 17 SEDAC subjects consisting of 2 familial and 7 sporadic cases and examined FOXC2 mutations by Sanger sequencing and structural abnormalities by TaqMan copy number assay. We identified 2 novel FOXC2 mutations in 2 familial cases. Incomplete LDS penetrance was noted in both families. Four subjects presented with SEDACs only. Thus, SEDAC caused by the heterozygous FOXC2 loss-of-function mutation should be considered a feature of LDS, although it often manifests as the sole symptom. Seven sporadic SEDAC subjects had no FOXC2 mutations, no symptoms of LDS, and showed differing clinical characteristics from those who had FOXC2 mutations, suggesting that other gene(s) besides FOXC2 are likely to be involved in SEDAC.
UR - http://www.scopus.com/inward/record.url?scp=84894250939&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894250939&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0080548
DO - 10.1371/journal.pone.0080548
M3 - Article
C2 - 24278289
AN - SCOPUS:84894250939
SN - 1932-6203
VL - 8
JO - PLoS One
JF - PLoS One
IS - 11
M1 - e80548
ER -